Literature DB >> 17589685

Laboratory results in ocular viral diseases: implications in clinical-laboratory correlation.

Fabiana Bogossian Marangon1, Darlene Miller, Eduardo Alfonso.   

Abstract

PURPOSE: To document etiology and predictive value of clinical diagnosis in laboratory confirmed viral diseases.
METHODS: Reports of culture-positive cases of samples collected from patients presenting from January 1987 - December 2001 were evaluated.
RESULTS: One thousand nine hundred and sixty-four (1964) cultures were submitted during 1987-2001. Twenty-six percent were positive (514). Human herpesvirus 1 was the most frequent agent isolated from all positive culture (56%). Adenovirus was the most common virus isolated from conjunctiva (66%), human herpesvirus 1 from lid and cornea (76%, 88%) and cytomegalovirus from vitreous (27%). Some unusual pathogens were recovered from conjunctiva as cytomegalovirus and from cornea as adenovirus, enterovirus and cytomegalovirus. Recognition of common viral syndromes was human herpesvirus 1 (88%), epidemic keratoconjunctivitis (88%), acute hemorrhagic conjunctivitis (70%) and varicella zoster virus (100%). However, some misdiagnosed cases were observed. Thirteen percent of conjunctivitis thought to be caused by herpes were due to adenovirus, 3.2% to Enterovirus, 3.2% to varicella zoster virus and 3.2% to human cytomegalovirus. Also, 5% of cases with a clinical diagnosis of herpes keratitis were caused by adenovirus and 2.7% by enterovirus. Finally, 4.8% of cases thought to be adenovirus conjunctivitis were herpes conjunctivitis.
CONCLUSIONS: Human herpesvirus 1 remains the most frequently isolated virus from ocular sites in general (56%). Nonherpetic corneal isolates were in decreasing order: adenovirus, enterovirus and cytomegalovirus. Clinical and laboratory correlation was less than 90%. The most misdiagnosed cases were herpes conjunctivitis and keratitis, some cases of adenovirus conjunctivitis some cases of acute hemorrhagic conjunctivitis. It is essential that a rapid and specific diagnosis is offered under atypical viral presentation for the institution of specific antiviral therapy and to avoid complications that can be a result of misdiagnosis and inappropriate treatment. Also it is important to do viral testing in order to confirm clinical diagnosis, report emerging infections, resistance and change in the epidemiology.

Entities:  

Mesh:

Year:  2007        PMID: 17589685     DOI: 10.1590/s0004-27492007000200002

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  5 in total

1.  HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium.

Authors:  Jihan Akhtar; Vaibhav Tiwari; Myung-Jin Oh; Maria Kovacs; Aarti Jani; S Krisztian Kovacs; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-23       Impact factor: 4.799

Review 2.  Herpes simplex keratitis: challenges in diagnosis and clinical management.

Authors:  Tayaba N Azher; Xiao-Tang Yin; Deena Tajfirouz; Andrew Jw Huang; Patrick M Stuart
Journal:  Clin Ophthalmol       Date:  2017-01-19

3.  Evaluation of multiplex real-time polymerase chain reaction for the detection of herpes simplex virus-1 and 2 and varicella-zoster virus in corneal cells from normal subjects and patients with keratitis in India.

Authors:  Sai Jeevana Madhuri Guda; Bhavani Sontam; Bhupesh Bagga; Konduri Ranjith; Savitri Sharma; Joveeta Joseph
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

Review 4.  Biological Staining and Culturing in Infectious Keratitis: Controversy in Clinical Utility.

Authors:  Majid Moshirfar; Grant C Hopping; Uma Vaidyanathan; Harry Liu; Anisha N Somani; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019

5.  Molecular identification of viral agents associated with acute conjunctivitis: a prospective controlled study.

Authors:  Emine Akçay; Ahmet Çarhan; Gözde Hondur; Zeliha Koçak Tufan; Necati Duru; Selçuk Kılıç; Ezgi Naz Ensari; Nagihan Uğurlu; Nurullah Çağıl
Journal:  Braz J Infect Dis       Date:  2017-05-20       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.